Clinton Group’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-37,503
Closed -$2.72M 1002
2016
Q2
$2.72M Buy
37,503
+25,253
+206% +$1.74M 0.12% 251
2016
Q1
$792K Sell
12,250
-51,945
-81% -$3.45M 0.05% 479
2015
Q4
$4.6M Buy
64,195
+43,134
+205% +$3.19M 0.37% 56
2015
Q3
$1.62M Buy
+21,061
New +$1.7M 0.15% 191
2015
Q2
Sell
-12,595
Closed -$913K 652
2015
Q1
$913K Buy
+12,595
New +$876K 0.24% 123
2014
Q4
Sell
-16,547
Closed -$907K 533
2014
Q3
$907K Buy
16,547
+10,368
+168% +$588K 0.37% 71
2014
Q2
$359K Buy
+6,179
New +$364K 0.18% 204
2014
Q1
Sell
-5,687
Closed -$304K 400
2013
Q4
$304K Buy
+5,687
New +$305K 0.1% 229
2013
Q3
Sell
-9,548
Closed -$437K 382
2013
Q2
$437K Buy
+9,548
New +$427K 0.14% 153

Other funds holding MD

Clinton Group's MD Position: Q3 2016 in Review

Clinton Group sold out of Pediatrix Medical (MD) in Q3 2016, closing a stake of 37,503 shares — an estimated $2.72M sold.

Clinton Group first reported a position in MD in Q2 2013 and held it in 9 quarters. The position peaked at $4.6M in Q4 2015. 381 funds tracked by Wall St. Rank hold MD as of Q3 2016.

  • Clinton Group reported no remaining Pediatrix Medical position as of Q3 2016 after selling out during the quarter.
  • Clinton Group sold 37,503 Pediatrix Medical shares in Q3 2016, an estimated $2.72M.
  • Clinton Group first reported a position in Pediatrix Medical in Q2 2013 and held it in 9 quarters.
  • Clinton Group's Pediatrix Medical position peaked at $4.6M in Q4 2015.
  • 381 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2016.

Based on Clinton Group's 13F filing for Q3 2016, filed 14 Nov 2016.